Statistics

Total Visits

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study93

Select a period of time:

Number of views in the range

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study23

Views

Views
October 20250
November 20255
December 20254
January 20263
February 20260
March 202611
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
United Kingdom4
Brazil2
Finland2
Argentina2
Chile1
Colombia1
Algeria1
Spain1
Mexico1
 

Top cities views

Views
San Jose2
Helsinki2
Amsterdam1
Ashburn1
Bogotá1
Edinburgh1
Guarujá1
Necochea1
Porlamar1
Santiago1